Authors:
Nsimba, SED
Aden-Abdi, Y
Rimoy, G
Massele, AY
Alm, C
Ericsson, O
Gustafsson, LL
Citation: Sed. Nsimba et al., Comparative in vitro and in vivo study of a sugar-coated chloroquine preparation marketed in Tanzania versus an ordinary brand, J CLIN PH T, 26(1), 2001, pp. 43-48
Authors:
Carrillo, JA
Christensen, M
Ramos, SI
Alm, C
Dahl, ML
Benitez, J
Bertilsson, L
Citation: Ja. Carrillo et al., Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine, THER DRUG M, 22(4), 2000, pp. 409-417
Authors:
Herrlin, K
Massele, AY
Rimoy, G
Alm, C
Rais, M
Ericsson, O
Bertilsson, L
Gustafsson, LL
Citation: K. Herrlin et al., Slow chloroguanide metabolism in Tanzanians compared with white subjects and Asian subjects confirms a decreased CYP2C19 activity in relation to genotype, CLIN PHARM, 68(2), 2000, pp. 189-198
Authors:
Wennerholm, A
Johansson, I
Massele, AY
Jande, M
Alm, C
Aden-Abdi, Y
Dahl, ML
Ingelman-Sundberg, M
Bertilsson, L
Gustafsson, LL
Citation: A. Wennerholm et al., Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype, PHARMACOGEN, 9(6), 1999, pp. 707-714